Photophysics and photobiology of novel liposomal formulations of 2,9(10), 16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II)

Six novel liposomal formulations of 2,9(10),16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II) (Pc9) were investigated to establish how the environments affect their photophysical and photobiological properties. The incorporation efficiency and solubility during a time pe...

Descripción completa

Detalles Bibliográficos
Autores: López Zeballos, Noelia del Carmen, Marino, Veronica Julieta, Garcia Vior, María Cecilia, Chiarante, Nicolás Agustín, Roguin, Leonor Patricia, Awruch, Josefina, Dicelio, Lelia Elina
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2013
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/16680
Acceso en línea:http://hdl.handle.net/11336/16680
Access Level:acceso abierto
Palabra clave:Photodynamic Therapy
Phthalocyanine
Singlet Oxygen
Photocytotoxicity
Liposome
Kb Cells
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
Descripción
Sumario:Six novel liposomal formulations of 2,9(10),16(17),23(24)-tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II) (Pc9) were investigated to establish how the environments affect their photophysical and photobiological properties. The incorporation efficiency and solubility during a time period were evaluated. All Pc9-liposomal formulations were efficient singlet oxygen quantum yield generators. The photobiological potentials were evaluated on human nasopharynx KB carcinoma cells. None of the formulations studied showed cytotoxic effects in the absence of light, whereas all of them showed good performance after irradiation. The 50% inhibition of cell proliferation (IC50) was in the range of 0.21–0.47 μM for Pc9-loaded liposome formulations. A lysosomal localization was found for S-PEG as well as for S.